HOPU Investments is an Asia-focused private equity firm headquartered in Hong Kong with additional offices in Beijing and Singapore. Founded in 2008, the firm specializes in large-scale proprietary investments including buyouts, carveouts, and strategic minority stakes across technology, logistics, consumer, and financial services sectors, with over $15 billion in assets under management.
Average disclosed round size is $216.2M (across 15 rounds with reported amounts).
Portfolio
10
Fund Size
—
Top Stage
Series C
Last 12 Mo
0
Team
DC
Danhua Chen
Managing Director
HY
Hong Yu
Managing Director
KP
Ke Peng
Managing Director
GH
Gunther Hamm
President
R(
Rebecca (Beike) Xu
Private Equity
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
15 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 XtalPi | Series D | $400M | Jan 2021 |
| AAmbrx Inc | Unknown | $45M | Nov 2020 |
 Perfect Diary | Unknown | $100M | Jan 2020 |
| LLyndra Therapeutics Inc. | Series C | $55M | Jan 2019 |
| LLyndra Therapeutics Inc. | Series B | $55M | Jan 2019 |
| GG7 | Growth | $320M | Dec 2018 |
| II-Mab Biopharma | Series C | $220M | Jun 2018 |
 I-MAB | Series C | $220M | Jun 2018 |
 SenseTime | Series C | $600M | Jan 2018 |
| I-MAB | Series C | $220M | Jan 2018 |
| II-Mab Biopharma | Ipo | $104M | Jan 2017 |
| AAmbrx Inc | Unknown | $45M | Jan 2016 |
 4Paradigm | Series D | $700M | — |
| LLyndra | Series B | $55M | — |
| I-MAB | Ipo | $104M | — |
Top Co-Investors
EDBI5 shared
Hillhouse Investment5 shared
Ally Bridge Group5 shared
The Invus Group, LLC5 shared
CDH Investments4 shared
Gilead Sciences3 shared
Polaris Partners3 shared
OrbiMed3 shared
Boyu Capital2 shared
HongShan2 shared
Sequoia Capital2 shared
Apricot Capital2 shared
Pivotal Life Sciences2 shared
Tiger Global Management, LLC2 shared
Bill & Melinda Gates Foundation2 shared
Osney Capital1 shared
Cambridge Capital1 shared
Staley Capital1 shared
Tencent Investment1 shared
GLP1 shared
Last updated: 20 October 2026